Source Feed: Ottawa Citizen
Author: Elizabeth Payne
Publication Date: February 28, 2026 - 04:00
Stay informed
Canada's Drug Agency says new Alzheimer's drug should not be publicly funded
February 28, 2026
A decision by Canada’s Drug Agency will make it more difficult for Canadians to access a drug shown to slow Alzheimer’s disease in some people, says an Ottawa cognitive neurologist and researcher. Read More
Unpublished Newswire
Listen in to the best on-ice moments from Canadian forward Rebecca Leslie as the Ottawa Charge lose to the Boston Fleet 3-2.
March 5, 2026 - 09:00 | | CBC News - Ottawa
The average selling price was down 7.1 per cent from February 2025 to $1,008,968, and the composite benchmark price was down 7.9 per cent year-over-year
March 5, 2026 - 08:48 | Globalnews Digital | Global News - Ottawa
The average selling price was down 7.1 per cent from February 2025 to $1,008,968, and the composite benchmark price was down 7.9 per cent year-over-year
March 5, 2026 - 08:48 | Globalnews Digital | Global News - Canada
Comments
Be the first to comment